Gestational Trophoblastic Disease (GTD) is a group of rare conditions that develop from abnormal growth of trophoblastic cells, the cells that normally form part of the placenta during pregnancy. GTD can occur during or after pregnancy and ranges from benign conditions such as hydatidiform mole (molar pregnancy) to malignant conditions collectively known as gestational trophoblastic neoplasia (GTN).
Early diagnosis, accurate monitoring, and appropriate treatment are important for effective management. Dr. Sarika Gupta, a gynecologic cancer specialist in Delhi, provides individualized evaluation and treatment planning for women with gestational trophoblastic disease.
Gestational trophoblastic disease includes several related conditions that originate from pregnancy-related trophoblastic tissue.
The main types include:
While many cases of molar pregnancy are not cancerous, some forms of GTD can persist or become malignant and require specialized cancer treatment.
Symptoms can vary depending on the type and stage of the condition. Possible signs include:
Not every patient experiences all of these symptoms. Any unusual bleeding or other concerning symptoms during or after pregnancy should be medically evaluated.
Diagnosis generally involves a combination of clinical assessment, blood tests, imaging, and tissue examination when required.
Evaluation may include:
Monitoring β-hCG levels is particularly important because persistent or rising levels may indicate that further treatment is required.
Treatment depends on the specific type of GTD, β-hCG levels, disease extent, previous treatment, and the patient's overall health.
A molar pregnancy is commonly treated by removing the abnormal pregnancy tissue. In selected circumstances, additional treatment may be required.
After treatment, regular β-hCG monitoring is important to confirm that the disease has resolved and to identify persistent disease early.
When trophoblastic disease persists or becomes malignant, it is known as gestational trophoblastic neoplasia.
Treatment may include:
The treatment approach is determined according to the type, stage, risk classification, and response to treatment.
Surgery may be required in selected patients, particularly for removal of molar pregnancy tissue or management of specific forms of trophoblastic disease.
The appropriate procedure depends on the patient's age, reproductive plans, disease characteristics, and clinical condition.
For selected patients requiring gynecological surgery, minimally invasive techniques may be considered when clinically appropriate.
Gestational trophoblastic disease requires careful diagnosis and follow-up because some forms can persist or progress despite initial treatment.
Dr. Sarika Gupta provides specialized gynecologic oncology evaluation and individualized treatment planning, helping patients understand their diagnosis, treatment options, and follow-up requirements.
Care may involve coordination with medical oncology, pathology, radiology, and other specialists when required.
Regular follow-up is an important part of GTD management. β-hCG monitoring is commonly used to determine whether treatment has been successful and whether any persistent disease remains.
Patients should follow their specialist's recommendations regarding:
Women searching for gestational trophoblastic disease treatment in Delhi, molar pregnancy treatment in Delhi, or a gynecologic cancer specialist in West Delhi can consult Dr. Sarika Gupta for evaluation and treatment planning.
Patients from Paschim Vihar, Punjabi Bagh, Rajouri Garden, Janakpuri, Pitampura, Rohini, and surrounding areas of West Delhi and North West Delhi can seek specialist consultation.
Gestational trophoblastic disease can often be treated successfully, but appropriate diagnosis and follow-up are essential. Persistent or abnormal β-hCG levels after treatment for a molar pregnancy require specialist evaluation.
Consult Dr. Sarika Gupta for personalized evaluation and treatment of gestational trophoblastic disease in Delhi.